In addition to Stim1, Orai1, and TRPC1, the lower ER Ca2+ content and slower decay to the baseline of ATP- and CPA-induced Ca2+ release suggest that other components of the Ca2+ toolkit are aberrantly expressed in RCC-EPCs. This evidence concerns the gene TRPC1 and renal cell carcinoma.